KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman On Q3 2020 Results - Quick Version Earnings Call Transcript

Karyopharm Therapeutics, Inc. (KPTI) Q3 2020 Earnings Conference Call October 2, 2020 16:20 AM ET Company Participants Ian Karp - VP, Investor & Public Relations Michael Kauffman - Co-Founder, CEO & Director John Demaree - Chief Commercial Officer Michael Mason - SVP, CFO & Treasurer Sharon Shacham - Co-Founder, President, Chief Scientific Officer & Co-Chairman, Scientific Advisory Board Conference Call Participants Jonathan Chang - SVB Leerink Maurice Raycroft - Jefferies Brian Abrahams - RBC Capital Markets Eric Joseph - JPMorgan Chase & Co. David Lebowitz - Morgan Stanley Michael Ulz - Robert W. Baird & Co. Ed White - H.C. Wainwright & Co. Peter Lawson - Barclays Bank Presentation Disclaimer: *NEW* We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure.

For further details see:

Karyopharm Therapeutics, Inc. (KPTI) CEO Michael Kauffman On Q3 2020 Results - Quick Version Earnings Call Transcript